MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-02-0003602
Valens Molecules Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹100.32 Cr
Latest filing
Net profit · FY 2025
₹11.17 Cr
Net margin 11.1%
EBITDA · FY 2025
₹23.98 Cr
EBITDA margin 23.9%
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹10.88 Cr
Issued & subscribed
Open charges
₹73.97 Cr
Satisfied ₹67.38 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
178
Provident fund records
About Valens Molecules Private Limited
Data last updated:
Valens Molecules Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 02 November 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG1994PTC018680. Its GSTIN is 36AABCP4726A1ZU (Telangana). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹10.88 Cr. It was formerly known as Posh Chemicals Pvt Ltd and Posh Chemicals Private Limited. It is led by directors including Cherukuri Surya Ratna Prasad (Managing Director) and Cherukuri Poshya (Whole-Time Director).
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 202 S.V.S Classic Residency 6 – 3 – 853/2 Ameerpet, Hyderabad, Telangana, India – 500016.
As per the financials filed for FY 2025, the company reported a revenue of ₹100.32 Cr. For the same year it recorded a net profit of ₹11.17 Cr (net margin 11.1%) and EBITDA of ₹23.98 Cr (EBITDA margin 23.9%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 13% over five years.
The company has about 178 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Valens Molecules. As per MCA filings, the company has open charges of ₹73.97 Cr and satisfied charges of ₹67.38 Cr on record. Court records list 12 cases involving the company, including 10 filed by the company and 2 filed against it; 7 cases are pending. The company has 13 deals on record (11 secondary share transfers, 2 rights issues); the latest was in September 2021. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Avik Pharmaceutical Limited with revenue of ₹103.38 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2024, listing 161 overdue payments to 34 micro and small suppliers.
Valens Molecules Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0003602). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website valensmolecules.com.
Company details
CIN U24100TG1994PTC018680
Registration Number 018680
Incorporation Date 02 November 1994
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 15 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0003602
Name history
Valens Molecules has undergone 2 name changes throughout its history. The company was previously known as Posh Chemicals Pvt Ltd, and Posh Chemicals Private Limited. The current legal name is Valens Molecules Private Limited.
| Company Name | Status |
|---|---|
| Valens Molecules Private Limited | Current |
| Posh Chemicals Pvt Ltd | Previous |
| Posh Chemicals Private Limited | Previous |
CIN history
Valens Molecules has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100TG1994PTC018680, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG1994PTC018680 | Current |
| U40102AP1994PTC018680 | Previous |
| U40102TG1994PTC018680 | Previous |
| U24230AP1994PTC018680 | Previous |
Key People
Cherukuri Surya Ratna Prasad Managing Director Cherukuri Poshya Whole-Time Director Padmasree Cherukuri Whole-Time Director Recognitions & Rankings of Valens Molecules
Contact details
Valens Molecules Private Limited's registered office is in Hyderabad, Telangana. Its website is valensmolecules.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address202 S.V.S Classic Residency 6 – 3 – 853/2 Ameerpet, Hyderabad, Telangana, India – 500016
- IndustryPharma, API Manufacturers
To see the full contact details of Valens Molecules Private Limited, buy the company report.
Comprehensive company report
Valens Molecules Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Valens Molecules operates one associated brand: Valens Molecules. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Valens Molecules is engaged in manufacturing APIs and specialty chemicals. | valensmolecules.com |
Business activity
The main business activity of Valens Molecules is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Valens Molecules Private Limited, buy the company report.
Financials of Valens Molecules Private Limited
FY 2025 filings availableValens Molecules Private Limited reported revenue of ₹100.32 Cr for FY 2025.
Revenue · FY 2025
₹100.32 Cr
Net profit · FY 2025
₹11.17 Cr margin 11.1%
EBITDA · FY 2025
₹23.98 Cr margin 23.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 1%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 12%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.98 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.17 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.9% | ||||
| Net Profit Margin | 11.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Valens Molecules Private Limited, buy the company report.
Board of directors of Valens Molecules Private Limited
Valens Molecules has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Cherukuri Poshya Also directs: Joie Ave LLP, Enpharm Private Limited | Whole-Time Director | 26 Aug 2006 | 20 Years 1 Months | Current |
| Padmasree Cherukuri | Whole-Time Director | 02 Nov 1994 | 31 Years 11 Months | Current |
| Cherukuri Ranga Prakash Also directs: Jeedimetla Effluent Treatment Limited. | Whole-Time Director | 24 Oct 2014 | 11 Years 11 Months | Current |
| Rahul Yalamanchili Also directs: Enpharm Private Limited, Georgetown Pharma Private Limited | Whole-Time Director | 07 Jan 2013 | 13 Years 9 Months | Current |
| Mulukutla Sambasiva Sastry | Director | 28 Aug 2001 | 25 Years 1 Months | Current |
| Cherukuri Surya Ratna Prasad | Managing Director | 02 May 1995 | 31 Years 5 Months | Current |
Peer comparison
Valens Molecules Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avik Pharmaceutical Limited | ₹103.38 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India | |||
| Sriven Pharmachem India Private Limited | ₹102.76 Cr (FY 2025) | 2.0% | Hyderabad, Telangana, India | |||
| Vineet Life Sciences Limited | ₹101.85 Cr (FY 2024) | 48.0% | Hyderabad, Telangana, India | |||
| Sna Healthcare Private Limited | ₹101.57 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Sarv Bio Labs Private Limited | ₹101.4 Cr (FY 2024) | -10.0% | Himachal Pradesh, India | |||
| Valens Molecules Private Limitedthis company | ₹100.32 Cr (FY 2025) | ₹11.17 Cr | 11.1% | 178 | Hyderabad, Telangana, India | |
| Ketul Chem Private Limited | ₹98.92 Cr (FY 2025) | 12.0% | Mumbai, Maharashtra, India | |||
| Warren Remedies Private Limited | ₹98.74 Cr (FY 2025) | 2320.0% | Aurangabad, Maharashtra, India | |||
| Benova Labs Private Limited | ₹98.59 Cr (FY 2025) | -6.0% | Hyderabad, Telangana, India | |||
| Teena Labs Limited | ₹96.94 Cr (FY 2024) | -46.0% | Hyderabad, Telangana, India | |||
| B G P Healthcare Private Limited | ₹95.66 Cr (FY 2025) | -1.0% | Ankleshwar, Gujarat, India |
To see the full peer comparison of Valens Molecules Private Limited, buy the company report.
Auditor
Valens Molecules Private Limited is audited by C.M.Rao & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C.M.Rao & Co. | FY 2023 | 003121S |
Shareholding
The shareholding of Valens Molecules Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Valens Molecules Private Limited, buy the company report.
Charges & borrowings
Open charges
₹73.97 Cr
Satisfied charges
₹67.38 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jul 2025 | 101144154 | Hdfc Bank Limited | ₹40 Lakh | Open | |
| 20 Jun 2025 | 101124269 | Hdfc Bank Limited | ₹13.14 Lakh | Open | |
| 29 Mar 2025 | 101107967 | Others | ₹1.1 Cr | Open | |
| 22 May 2024 | 100930047 | Hdfc Bank Limited | ₹97 Lakh | Open | |
| 21 Dec 2023 | 100844329 | Others | ₹1.06 Cr | Open |
To see the full charge records of Valens Molecules Private Limited, buy the company report.
Total charge records: 23 View all charges
Deals & funding
Valens Molecules Private Limited has 13 deals on record (11 secondary share transfers, 2 rights issues); the latest was in September 2021.
Total deals
13
Secondary share transfers
11
Rights issues
2
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Valens Molecules Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Valens Molecules Private Limited has 12 court cases on record: 10 filed by Valens Molecules, 2 filed against it. 7 cases are pending and 5 are disposed.
Total cases
12
Filed by the company
10
Filed against the company
2
Pending
7
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 2 | 5 |
| District courts | 2 | 0 | 2 |
| Supreme Court | 2 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Court case (WP(PIL)) | Filed against the company | Pending |
| District court, Kamareddy, Telangana | Civil suit | Filed by the company against an individual | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against Telangana State Southern Power Distribution Company Limited and 2 others | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against The State of Telangana and 4 others | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against Telangana State Southern Power Distribution Company Limited and 4 Others and 4 others | Pending |
To see the full case history of Valens Molecules Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Valens Molecules Private Limited was last rated by Crisil on 25 Aug 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 25 Aug 2020 |
To see the full credit ratings and regulatory alerts of Valens Molecules Private Limited, buy the company report.
MSME payment delays
Valens Molecules Private Limited has 11 MSME Form 1 returns on record between 2019 and 2024, listing 161 overdue payments to 34 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 34)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pragati Polyplast India Private Limited | |||
| an individual supplier | |||
| Evershine Tools Traders | |||
| an individual supplier | |||
| Srse Cleanrooms Technologies Private Limited |
To see the full MSME payment records of Valens Molecules Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Valens Molecules Private Limited has a workforce of 178 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
178
Active EPFO establishments
1
Employee growth
-6.81%
GST
Valens Molecules has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCP4726A1ZU | Telangana | Active | 01 Jul 2017 |
| 36AABCP4726A2ZT | Telangana | Active | 27 Mar 2025 |
| 37AABCP4726A1ZS | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Valens Molecules Private Limited, buy the company report.
Recent activity
Valens Molecules Private Limited has 13 board changes on record since 1994: 6 appointments and 7 cessations. The latest: Ashok Prabhakar Mayekar ceased to be Director on 28 Apr 2019.
AGM
Valens Molecules Private Limited last Annual general meeting of members was held on 15 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.40 Cr with Charge ID 101144154 was registered on 21 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.13 Cr with Charge ID 101124269 was registered on 20 Jun 2025.
Charges
A charge registered on 28 Jan 2021 via Charge ID 100417397 with Others was fully satisfied on 28 Apr 2025.
Filing
Valens Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 1.10 Cr with Charge ID 101107967 was registered on 29 Mar 2025.
Charges
A charge registered on 12 Sep 2019 via Charge ID 100299076 with Others was fully satisfied on 21 Jan 2025.
Charges
A charge registered on 31 Dec 2019 via Charge ID 100324378 with Others was fully satisfied on 09 Jul 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.97 Cr with Charge ID 100930047 was registered on 22 May 2024.
Charges
A charge with Others amounted to Rs. 1.06 Cr with Charge ID 100844329 was registered on 21 Dec 2023.
Charges
A charge with Others amounted to Rs. 0.30 Cr with Charge ID 100819480 was registered on 03 Nov 2023.
Charges
A charge registered on 16 Oct 2017 via Charge ID 100133243 with Others was fully satisfied on 07 Jun 2023.
43 earlier events are in the company report.
Frequently asked questions
Valens Molecules is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 02 November 1994 (32+ years old) and is registered under CIN U24100TG1994PTC018680.
Valens Molecules has 6 current directors:
- Cherukuri Surya Ratna Prasad - Managing Director
- Cherukuri Poshya - Whole-Time Director
- Padmasree Cherukuri - Whole-Time Director
- Cherukuri Ranga Prakash - Whole-Time Director
- Rahul Yalamanchili - Whole-Time Director
- Mulukutla Sambasiva Sastry - Director
The latest financial statements of Valens Molecules on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Valens Molecules is 36AABCP4726A1ZU, registered in Telangana. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 36AABCP4726A2ZT (Telangana), 37AABCP4726A1ZS (Andhra Pradesh).
The CIN (Corporate Identification Number) of Valens Molecules is U24100TG1994PTC018680. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Valens Molecules has 12 court cases on record: 10 filed by the company and 2 filed against it. 7 are pending. Most are in the high courts.
Valens Molecules was incorporated on 02 November 1994, making it 32+ years old. It is registered with the Registrar of Companies, Hyderabad.
Valens Molecules has 13 deals on record (11 secondary share transfers, 2 rights issues); the latest was in September 2021.
The peers of Valens Molecules by revenue are Avik Pharmaceutical Limited, Sriven Pharmachem India Private Limited, Vineet Life Sciences Limited, Sna Healthcare Private Limited, Sarv Bio Labs Private Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashok Prabhakar Mayekar ceased to be Director on 28 Apr 2019. Cherukuri Poshya ceased to be Director on 01 Apr 2019. Mulukutla Sambasiva Sastry ceased to be Whole-Time Director on 01 Apr 2019. Valens Molecules has 13 board changes on record in total.
Yes, Valens Molecules is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0003602).
Valens Molecules has 11 MSME Form 1 returns on record between 2019 and 2024, listing 161 overdue payments to 34 micro and small suppliers. The latest return was filed on 01 May 2024.